Off-Target Identification


Increase your success rate at an early stage. With pharmAI's rapid off-target prediction service, you can find potential off-targets already during discovery stage.




Get control over potential off-target complications prior to further investments.



Off target identification covering the human proteome


Drugs may not always do only what we think they do. Many proposed new drug candidates fail clinical trials due to undesired and potentially harmful side-effects posing significant scientific and economic risks.

PharmAI’s DiscoveryEngine searches among hundreds of thousands of proteins and drugs for associations and off-targets using a groundbreaking combination of 3D protein structure data and artificial intelligence.



Accelerated workflow

Our optimized workflow predicts potential off-target proteins from the set of human proteome in less than four weeks. Our screening covers 95% of known human drug targets and de-risks your drug discovery journey at an early stage.


Want to know more?

In our white paper , we showcase how the combination of in silico screening and state-of-the-art biophysics was applied to rapidly identify off-targets for a MAPK14 inhibitor.

Top